+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dynavax Technologies Corporation - logo

Dynavax is a clinical-stage biopharmaceutical company with multiple product candidates in development for the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. The company’s lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine; and AZD1419, which is in Phase II clinical trial for the treatment of asthma. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.

Liver Fibrosis Market Report and Forecast 2024-2032 - Product Thumbnail Image

Liver Fibrosis Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Acute Pancreatitis Global Market Report 2024 - Product Thumbnail Image

Acute Pancreatitis Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Myocardial Infarction Global Market Report 2024 - Product Thumbnail Image

Myocardial Infarction Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Angina Pectoris Drugs Global Market Report 2024 - Product Thumbnail Image

Angina Pectoris Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Autologous Cell Therapy Global Market Report 2024 - Product Thumbnail Image

Autologous Cell Therapy Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Medical & Clinical Research - Global Industry Report - Product Thumbnail Image

Medical & Clinical Research - Global Industry Report

  • Report
  • November 2024
  • 1510 Pages
  • Global
From
From
From
Loading Indicator